Profile: Elekta publ AB (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

81.00SEK
19 Dec 2014
Price Change (% chg)

0.70kr (+0.87%)
Prev Close
80.30kr
Open
80.65kr
Day's High
81.45kr
Day's Low
80.05kr
Volume
1,818,743
Avg. Vol
2,367,445
52-wk High
100.90kr
52-wk Low
63.95kr

Search Stocks
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. In July 2014, it acquired Mesi Medikal A.S., distributor of radiation oncology solutions in Turkey.

Company Address

Elekta publ AB

Box 7593, Kungstensgatan 18
STOCKHOLM     103 93
P: +468.58725400
F: +468.58725500

Search Stocks